Asthma and Respiratory Disorders News

Adults with asthma experienced more exacerbations and acute respiratory infections after COVID-19 restrictions were relaxed, according to study results published in Thorax.

Adults who were taking dupilumab for their atopic dermatitis also experienced significant improvements in their mild asthma, primarily in the first 16 weeks, according to a study published in Clinical and Translational Allergy.

In patients with severe, uncontrolled asthma, tezepelumab reduced the rate of asthma exacerbations and was tolerated for up to 2 years, according to an extension study published in The Lancet Respiratory Medicine.

Change is far from incremental in allergy and asthma care based on the speakers and presentations scheduled for the American Academy of Allergy, Asthma & Immunology Annual Meeting in San Antonio from Feb. 24 to 27.

The prevalence of asthma rose slightly among teens and youth from some race/ethnicity groups in states with recreational cannabis laws compared with states where cannabis is illegal, according to a study published in Preventive Medicine.

Defined as three or more canisters a year, overuse of short-acting beta 2 agonists was associated with increased risk for exacerbations among children with asthma, according to a study published in Pediatric Allergy and Immunology.

Genetic variants related to GERD heightened risks for both asthma and atopic dermatitis by 21%, according to study results published in American Journal of Respiratory and Critical Care Medicine.

Vitamin D supplements did not reduce asthma exacerbations or improve asthma control among adults or children, according to an updated Cochrane review, contradicting an earlier review showing benefits of supplementation.

During the COVID-19 pandemic, loneliness, family conflict and difficultly accessing health care raised the risk for first-time and recurrent depression among older adults with asthma, according to a study published in Respiratory Medicine.

Residential exposure to moisture damage and mold during infancy had a dose-dependent association with wheeze later in childhood, according to a study published in Pediatric Allergy and Immunology.